Strong Revenue and Profit Growth
Revenue increased 6.7% versus prior year quarter; adjusted EBITDA grew ~11% in the quarter and 12.1% for the full year; adjusted EBITDA margin improved ~80 bps in the quarter and 90 bps for the year; net income attributable to HCA increased ~31% and adjusted diluted EPS rose ~29%.
Record Patient Activity and Consistent Volume Growth
Company recorded ~47 million patient encounters for the year (a record) and reported the nineteenth straight quarter of volume growth; same-facility admissions increased ~2.4% and equivalent admissions increased ~2.4%-2.5% (quarter and full year figures consistent with 2%-3% long-term range).
Cash Flow, Capital Allocation and Shareholder Returns
Operating cash flow of $2.4B in the quarter and $12.6B for the year (a 20% YoY increase); FY capital expenditures $4.9B; share repurchases $2.6B in the quarter and $10B for the year; board authorized a new $10B repurchase program and raised the quarterly dividend from $0.72 to $0.78.
2026 Financial Guidance Reflects Resilience
2026 guidance: revenues $76.5B–$80.0B; adjusted EBITDA $15.55B–$16.45B; net income $6.5B–$7.0B; adjusted diluted EPS $29.01–$31.50; full-year margins expected slightly above 20%; cash flow from operations expected $12B–$13B.
Operational Improvements and Resiliency Program
Management highlighted disciplined expense management, improved labor results and other operating expense improvements driving margin expansion; resiliency program is expected to deliver approximately $400M of incremental savings in 2026 through revenue integrity, cost efficiencies, capacity management and digital/AI initiatives.
Investments in Network, Outpatient Footprint and Technology
Significant investments in network expansion, workforce, clinical capabilities and AI/tech (EHR transition underway); added ~100 outpatient business units during the year (company now ~2,700 outpatient facilities) and increased 2026 capex range to $5.0B–$5.5B to support growth.
Improved Working Capital and Revenue Cycle Progress
Notable reduction in net days in accounts receivable in Q4 attributed in part to digital integration with payers; digital engagements expected to improve claims timeliness, reduce denials and support collections.